NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00003643,Combination Chemotherapy in Treating Men With Germ Cell Cancer,https://clinicaltrials.gov/study/NCT00003643,,UNKNOWN,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which regimen of combination chemotherapy may be more effective for germ cell cancer.

PURPOSE: This randomized phase II/III trial is studying two different regimens of combination chemotherapy and comparing how well they work in treating men with germ cell cancer.",NO,Extragonadal Germ Cell Tumor|Teratoma|Testicular Germ Cell Tumor,BIOLOGICAL: bleomycin sulfate|BIOLOGICAL: filgrastim|DRUG: cisplatin|DRUG: etoposide|DRUG: paclitaxel,Failure-free survival as measured by Logrank,"Response to treatment as measured by normalized markers without residual viable cancer after CT scan or surgery|Overall survival as measured by Logrank at end of each course, at 6 weeks after completion of study treatment, every 6 months up to year 5, and then annually thereafter|Disease-free survival as measured by Logrank at end of each course, at 6 weeks after completion of study treatment, every 6 months up to year 5, and then annually thereafter|Toxicity as measured by NCI-CTC v2.0 at end of each course, at 6 weeks after completion of study treatment, every 6 months up to year 5, and then annually thereafter|Quality of life as measured by Quality of Life Questionnaire Core 30 (QLQ-C30) at baseline, during treatment, and at years 1 and 2",,European Organisation for Research and Treatment of Cancer - EORTC,,MALE,"CHILD, ADULT",PHASE2|PHASE3,498,NETWORK,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,EORTC-30983|EORTC-30983,1998-10,,,2003-01-27,,2012-03-06,"Ludwig Boltzmann Institute for Applied Cancer Research at Kaiser Franz Josef Hospital, Vienna, A-1100, Austria|Institut Jules Bordet, Brussels, 1000, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, B-2650, Belgium|U.Z. Gasthuisberg, Leuven, B-3000, Belgium|Aarhus Universitetshospital - Aarhus Sygehus, Aarhus, DK-8000, Denmark|Rigshospitalet - Copenhagen University Hospital, Copenhagen, 2100, Denmark|Centre Regional Francois Baclesse, Caen, 14076, France|Institut Claudius Regaud, Toulouse, 31052, France|Institut Gustave Roussy, Villejuif, F-94805, France|Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, D-12200, Germany|Universitaetsklinikum Bonn, Bonn, D-53105, Germany|St. Johannes Hospital - Medical Klinik II, Duisburg, D-47166, Germany|Universitaetsklinikum Essen, Essen, D-45122, Germany|Klinik Fuer Innere Medizin, Hematology/Oncology, Ernst Moritz Armdt Universitaet, Greifswald, D-17487, Germany|Allgemeines Krankenhaus Hagen, Hagen, D-58095, Germany|Universitaetsklinikum Halle, Halle, DOH-06112, Germany|University Medical Center Hamburg - Eppendorf, Hamburg, D-20246, Germany|Universitaetsklinikum des Saarlandes, Homburg, D-66421, Germany|Klinikum Kassel, Kassel, D-34125, Germany|Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen am Rhein, D-67063, Germany|Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg, Magdeburg, D-39120, Germany|Klinikum der Stadt Mannheim, Mannheim, D-68135, Germany|Universitaetsklinikum Giessen und Marburg GmbH - Marburg, Marburg, D-35033, Germany|Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster, Muenster, D-48149, Germany|Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich, D-81675, Germany|Klinikum Nuernberg - Klinikum Nord, Nuremberg, D-90419, Germany|Klinikum der Universitaet Regensburg, Regensburg, D-93053, Germany|Klinikum Schwerin, Schwerin, D-19049, Germany|Southwest German Cancer Center at Eberhard-Karls-University, Tuebingen, D-72076, Germany|National Institute of Oncology, Budapest, 1125, Hungary|Assaf Harofeh Medical Center, Zerifin, 70300, Israel|Ospedale di Circolo e Fondazione Macchi, Varese, 21100, Italy|Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, 5211 NL, Netherlands|Academisch Medisch Centrum at University of Amsterdam, Amsterdam, 1105 AZ, Netherlands|Leiden University Medical Center, Leiden, 2300 CA, Netherlands|Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen, NL-6500 HB, Netherlands|University Medical Center Rotterdam at Erasmus Medical Center, Rotterdam, 3000 CA, Netherlands|Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, 3008 AE, Netherlands|University Medical Center Utrecht, Utrecht, 3584 CX, Netherlands|Norwegian Radium Hospital, Oslo, N-0310, Norway|Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology - Warsaw, Warsaw, 02 781, Poland|National Cancer Institute - Bratislava, Bratislava, 833 10, Slovakia|Hospital de la Santa Cruz i Sant Pau, Barcelona, 08025, Spain|Vall d'Hebron University Hospital, Barcelona, 08035, Spain|Institut Catala D'Oncologia, Barcelona, 08907, Spain|Hospital Universitario San Carlos, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario Virgen de la Victoria, Malaga, 29010, Spain|Hospital Sant Joan de Reus, Reus, 43201, Spain|Hospital Universidad Virgen Del Rocio, Sevilla, E- 41013, Spain|Hospital Universitario La Fe, Valencia, 46009, Spain|Hospital Clinico Universitario Lozano Blesa, Zaragoza, 50009, Spain|Addenbrooke's Hospital, Cambridge, England, CB2 2QQ, United Kingdom|Gloucestershire Oncology Centre at Cheltenham General Hospital, Cheltenham, England, GL53 7AN, United Kingdom|Leeds Cancer Centre at St. James's University Hospital, Leeds, England, LS9 7TF, United Kingdom|Saint Bartholomew's Hospital, London, England, EC1A 7BE, United Kingdom|University College Hospital - London, London, England, WC1E 6AU, United Kingdom|Christie Hospital, Manchester, England, M20 4BX, United Kingdom|Nottingham City Hospital NHS Trust, Nottingham, England, NG5 1PB, United Kingdom|Rosemere Cancer Centre at Royal Preston Hospital, Preston, England, PR2 9HT, United Kingdom|Berkshire Cancer Centre at Royal Berkshire Hospital, Reading, England, RG1 5AN, United Kingdom|Cancer Research Centre at Weston Park Hospital, Sheffield, England, S1O 2SJ, United Kingdom|Royal South Hants Hospital, Southampton, England, SO14 0YG, United Kingdom|Royal Marsden - Surrey, Sutton, England, SM2 5PT, United Kingdom|Southend University Hospital NHS Foundation Trust, Westcliff-On-Sea, England, SS0 0RY, United Kingdom|Aberdeen Royal Infirmary, Aberdeen, Scotland, AB25 2ZN, United Kingdom|Western Infirmary, Glasgow, Scotland, G11 6NT, United Kingdom|Gartnavel General Hospital, Glasgow, Scotland, G12 0YN, United Kingdom|Velindre Cancer Center at Velindre Hospital, Cardiff, Wales, CF4 7XL, United Kingdom",
